Day: March 9, 2023

Declares Regular Quarterly Dividend GARDEN CITY, N.Y., March 09, 2023 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, today reported its financial results for the quarter and full year ended December 31, 2022. Rob Kay, Lifetime’s Chief Executive Officer, commented, “Our core business continues to deliver solid performance in the face of industrywide challenges, as a result of our strong market share position and proactive cost management actions. Our fourth quarter results reflect the ongoing impact of reduced orders from our customers as retailers continue to focus on rightsizing their inventory levels. Inflationary and other macro-economic challenges also contributed to weaker end market demand, especially...

Recovery continues, driving both Revenue and Profit growth MISSISSAUGA, Ontario, March 09, 2023 (GLOBE NEWSWIRE) — KP Tissue Inc. (KPT) (TSX: KPT) reports the Q4 2022 and full year 2022 financial and operational results of KPT and Kruger Products L.P. (KPLP). Kruger Products is Canada’s leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and Bonterra™) and the Away-From-Home (AFH) market and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 13.7% interest in Kruger Products. KPLP Q4 2022 Business and Financial HighlightsRevenue was $458.1 million in Q4 2022 compared to $424.1 million in Q4 2021, an increase of $34.0 million or 8.0%. Adjusted EBITDA1...

PLANO, Texas, March 09, 2023 (GLOBE NEWSWIRE) — Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT), an e-commerce-focused financial technology company, today reported its financial results for the fourth quarter ended December 31, 2022. Orlando Zayas, CEO of Katapult said, “I am proud that our team successfully executed against the strategic investment roadmap that we shared in early 2022, highlighted by new technology, such as enhancing our mobile app with a new feature called Katapult PayTM, our one-time use virtual card technology that makes lease purchasing simple and intuitive for our customers. The early success of these investments is reflected in our fourth quarter results with a return to growth in gross originations of 1.5% year-over-year, despite a challenging macro backdrop for consumers and retailers....

CHICAGO, March 09, 2023 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) (“Chicago Atlantic” or the “Company”), a commercial real estate finance company, today announced its results for the fourth quarter and year ended December 31, 2022. John Mazarakis, Executive Chairman of Chicago Atlantic, noted, “The safety and stability of our dividend is paramount, and we have worked hard to assemble a well-diversified portfolio with strong real estate and other asset collateral to create a fortress balance sheet. Cannabis lending is a nascent industry with tremendous upside within the limited-license states in the U.S. accompanied by a rapidly changing environment that requires constant vigilance. Our focus on creating a long-term, sustainable platform has positioned us to trade faster loan portfolio growth for...

BOSTON, March 09, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and world leader in galectin biology focused on the development of novel treatments for fibrosis and cancer, today announced its operating and financial results for the quarter and year ended December 31, 2022. “2022 was an exciting year for us as we continued to progress our pipeline of small-molecule inhibitors of galectin-3 and LOXL2 and we now have three novel compounds in Phase 2 supported by positive clinical data. We are highly encouraged by the clinical results reported in 2022, including with GB1211 in decompensated liver cirrhosis and with GB2064 in myelofibrosis, which provide further evidence of the key roles of galectin-3 and LOXL2 in regulating fibrosis,” said Hans Schambye, CEO of Galecto. “We are looking...

CICERO, Ill., March 09, 2023 (GLOBE NEWSWIRE) — Broadwind, Inc. (Nasdaq: BWEN, “Broadwind” or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced results for the fourth quarter and full-year 2022. FOURTH QUARTER 2022 RESULTS(As compared to the fourth quarter 2021)Total revenue of $40.1 million, +54.0% y/y Total gross profit of $2.6 million, +$1.6 million y/y Total non-GAAP adjusted EBITDA of $0.2 million, +$1.4 million y/y Total orders of $204.8 million, +$149.1 million y/y Total backlog of $297.2 million, +$190.8 million y/y Total cash and excess availability of $40.1 million, +$25.2 million y/yFULL-YEAR 2022 RESULTS(As compared to the full-year 2021)Total revenue of $176.8 million, +21.4% y/y Total gross profit of $10.7 million, +94.3% y/y Total...

Record Electric and Hybrid Vehicle Application Sales Strong Free Cash Flow $8 Million in Share Buybacks Announced Cash Offer to Acquire Nordic Lights Group CorporationCHICAGO, March 09, 2023 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, LED lighting and power distribution applications, today announced financial results for the third quarter of fiscal 2023 ended January 28, 2023. Fiscal Third Quarter 2023 HighlightsNet sales were $280.1 million, of which electric and hybrid vehicle applications were a record 24 percent Compared to the third quarter of fiscal 2022, net sales were down 3.9%. Excluding foreign currency and cost recovery impacts, net sales were up 3.8% Other expense was negatively impacted $7.5 million due to higher foreign...

Achieves 11% Annual Growth in Recurring Revenue OTTAWA, March 09, 2023 (GLOBE NEWSWIRE) — ProntoForms Corporation (TSXV: PFM), the global leader in field intelligence, announced today its annual and fourth quarter (Q4) financial results for the period ended December 31, 2022. All amounts are in US dollars unless otherwise stated. “In 2022, we grew our recurring revenue by 11% as we continued to develop our enterprise go-to-market teams and by the 4th quarter made solid progress in closing the gap to EBITDA breakeven,” said Alvaro Pombo, Founder and co-CEO of ProntoForms. “We have achieved notable successes in expanding our footprint in major enterprise customers based on the strong return on investment that our platform continues to deliver. In the last quarter, we announced a major expansion at a global oil company valued at $2.5...

― Company is working to address clinical hold on the Investigational New Drug application for FTX-6058 for the potential treatment of sickle cell disease ― ― FTX-6058 data from 12 mg cohort of Phase 1b trial show clinically relevant fetal hemoglobin increases of up to 10.0% ― ― On track to complete enrollment in Phase 3 REACH trial of losmapimod in facioscapulohumeral muscular dystrophy during 2H’23 ― ― In 1Q’23 completed public offering, generating approximately $117.3 million in net proceeds; Cash runway guidance into mid-2025 ― ― Company announces departure of Chief Medical Officer Santiago Arroyo, MD, Ph.D.; Appoints Iain Fraser, MBChB, D.Phil, as Interim Chief Medical Officer ― ― Conference call and webcast scheduled for 8:00 a.m. ET today ― CAMBRIDGE, Mass., March 09, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the...